共 134 条
[1]
Schmoll HJ(2012)ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making Ann Oncol 23 2479-2516
[2]
Van Cutsem E(2016)Impact of patient factors on recurrence risk and time dependency of oxaliplatin benefit in patients with colon cancer: analysis from modern-era adjuvant studies in the adjuvant colon cancer end points (ACCENT) database J Clin Oncol 34 843-853
[3]
Stein A(2004)Multicenter international study of oxaliplatin/5-fluorouracil/leucovorin in the adjuvant treatment of colon cancer (MOSAIC) investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer N Engl J Med 350 2343-2351
[4]
Valentini V(2016)Increased lymph node retrieval decreases adjuvant chemotherapy rate for stage II colon cancer Scand J Gastroenterol 51 949-955
[5]
Glimelius B(2018)Acetone clearance of mesocolic or mesorectal fat increases lymph node yield and may improve detection of high-risk Stage II colorectal cancer patients Colorectal Dis 20 1014-1019
[6]
Haustermans K(2014)Potential causes of stage migration and their prognostic implications in colon cancer: a nationwide survey of specialist institutions in Japan Jpn J Clin Oncol 44 547-555
[7]
Shah MA(2017)Safety of laparoscopic surgery for colorectal cancer in patients over 80 years old: a propensity score matching study Surg Today 47 951-958
[8]
Renfro LA(2011)Association between lymph node evaluation for colon cancer and node positivity over the past 20 years JAMA 306 1089-1097
[9]
Allegra CJ(2007)Hospital lymph node examination rates and survival after resection for colon cancer JAMA 298 2149-2154
[10]
André T(2007)Factors affecting the number of lymph nodes retrieved in colorectal cancer specimens Surg Endosc 21 2142-2146